Immune supplementation and immune modulation with intravenous immunoglobulin

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 4, 2005, Pages 941-944

  Mazer, Bruce D ^a   Al Tamemi, Salem ^a   Yu, Joyce W ^a   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; STEROID;

ARTICLE; ASTHMA; ATOPY; B LYMPHOCYTE; BRONCHIECTASIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL TRIAL; COMMON VARIABLE IMMUNODEFICIENCY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; GUILLAIN BARRE SYNDROME; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERIMMUNOGLOBULINEMIA M; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOMODULATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYASTHENIA GRAVIS; PNEUMONIA; POLYNEUROPATHY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SINUSITIS; T LYMPHOCYTE; X LINKED AGAMMAGLOBULINEMIA;

DIGEORGE SYNDROME; GUILLAIN-BARRE SYNDROME; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MUCOCUTANEOUS LYMPH NODE SYNDROME; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 25844452674     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.07.021     Document Type: Article

References (23)

1. L. Notarangelo, J.L. Casanova, A. Fischer, J. Puck, F. Rosen, and R. Seger Primary immunodeficiency diseases: an update J Allergy Clin Immunol 114 2004 677 687
2. E. Merler, F.S. Rosen, S. Salmon, J.D. Crain, and C.A. Janeway Studies with intravenous gamma globulin Vox Sang 13 1967 102 103
3. C.A. Janeway, and F.S. Rosen The gamma globulins. IV. Therapeutic uses of gamma globulin N Engl J Med 275 1966 826 831
4. F.S. Rosen, and C.A. Janeway The gamma globulins. 3. The antibody deficiency syndromes N Engl J Med 275 1966 769 775
5. R.P.J. Nelson, and M. Ballow Immunomodulation and immunotherapy: drugs, cytokines, cytokine receptors, and antibodies J Allergy Clin Immunol 111 suppl 2003 S720 S743
6. F.A. Bonilla, I.L. Bernstein, D.A. Khan, Z.K. Ballas, J. Chinen, and M.M. Frank Practice parameter for the diagnosis and management of primary immunodeficiency Ann Allergy Asthma Immunol 94 suppl 2005 S1 S63
7. A. Gardulf, U. Nicolay, D. Math, O. Asensio, E. Bernatowska, and A. Bock Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home J Allergy Clin Immunol 114 2004 936 942
8. S. Radinsky, and V.R. Bonagura Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin J Allergy Clin Immunol 112 2003 630 633
9. M.L. Markert, M.J. Alexieff, J. Li, M. Sarzotti, D.A. Ozaki, and B.H. Devlin Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases J Allergy Clin Immunol 113 2004 734 741
10. R.H. Buckley Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution Annu Rev Immunol 22 2004 625 655
11. R.H. Buckley Transplantation immunology: organ and bone marrow J Allergy Clin Immunol 111 suppl 2003 S733 S744
12. R.H. Buckley A historical review of bone marrow transplantation for immunodeficiencies J Allergy Clin Immunol 113 2004 793 800
13. B.A. Binstadt, R.S. Geha, and F.A. Bonilla IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy J Allergy Clin Immunol 111 2003 697 703
14. V. Siragam, D. Brinc, A.R. Crow, S. Song, J. Freedman, and A.H. Lazarus Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? J Clin Invest 115 2005 155 160
15. R. Clynes Immune complexes as therapy for autoimmunity J Clin Invest 115 2005 25 27
16. P. Bruhns, A. Samuelsson, J.W. Pollard, and J.V. Ravetch Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease Immunity 18 2003 573 581
17. D.Y. Leung, H.C. Meissner, S.T. Shulman, W.H. Mason, M.A. Gerber, and M.P. Glode Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease J Pediatr 140 2002 742 746
18. J. Abe, T. Jibiki, S. Noma, T. Nakajima, H. Saito, and M. Terai Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease J Immunol 174 2005 5837 5845
19. I. Nomura, J. Abe, S. Noma, H. Saito, B. Gao, and G. Wheeler Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study Pediatr Res 57 2005 49 55
20. N. Misra, J. Bayry, A. Ephrem, S. Dasgupta, S. Delignat, and J.P. Van Huyen Intravenous immunoglobulin in neurological disorders: a mechanistic perspective J Neurol 252 suppl 1 2005 i1 i6
21. B.D. Mazer, and E.W. Gelfand An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma J Allergy Clin Immunol 87 1991 976 983
22. J.D. Spahn, D.Y. Leung, M.T. Chan, S.J. Szefler, and E.W. Gelfand Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin J Allergy Clin Immunol 103 1999 421 426
23. K. Sigman, F. Ghibu, W. Sommerville, B.J. Toledano, Y. Bastein, and L. Cameron Intravenous immunoglobulin inhibits IgE production in human B lymphocytes J Allergy Clin Immunol 102 1998 421 427